CyTOF analysis of these tumors revealed that the CCR2+ admixed tumors had significantly fewer CD11b+ myeloid cells and significantly increased CD8+ T-cells present within the tumor (Fig. 7c, d). This evidence concerns the gene CCR2 and neoplasm.